| (Values in U.S. Thousands) | Mar, 2023 | Dec, 2022 | Sep, 2022 | Jun, 2022 | Mar, 2022 |
| Sales | 3,820 | 3,020 | 1,730 | 1,770 | 260 |
| Sales Growth | +26.49% | +74.57% | -2.26% | +580.77% | unch |
| Net Income | -28,470 | -38,760 | -38,160 | -51,930 | -38,210 |
| Net Income Growth | +26.55% | -1.57% | +26.52% | -35.91% | -230.82% |
Greenlight Biosciences Hldgs Pbc (GRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
GreenLight Biosciences Inc. is a biotechnology company dedicated to making ribonucleic acid products for human health and agriculture. GreenLight Biosciences Inc., formerly known as Environmental Impact Acquisition Corporation, is based in BOSTON.
Fiscal Year End Date: 12/31